STOCK TITAN

Caring Brands (NASDAQ: CABR) receives Nasdaq Staff Delisting Determination

(Moderate)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Caring Brands, Inc. reports that Nasdaq’s Listing Qualifications Staff issued a Staff Delisting Determination after the company failed to meet Nasdaq Listing Rule 5550(b). The company had stockholders’ equity of $2,091,324, below the required $2.5 million, and did not meet the alternative continued listing standards for market value or net income.

The Determination denies the company’s request for continued listing. Unless a hearing is requested by 4:00 p.m. ET on July 22, 2026, trading in its common stock will be suspended at the opening on July 24, 2026 and Nasdaq will file a Form 25-NSE. Caring Brands intends to request a hearing and pay the applicable fee by July 21, 2026, which would stay any suspension pending a Panel decision, but there is no assurance the company will regain or maintain compliance.

Positive

  • None.

Negative

  • Nasdaq delisting risk: Nasdaq’s Listing Qualifications Staff issued a Staff Delisting Determination denying continued listing, creating a risk of trading suspension and delisting if a hearing is not successfully obtained and compliance is not regained.
  • Equity below requirement: Stockholders’ equity was $2,091,324, below Nasdaq’s $2.5 million minimum, and the company also failed to meet alternative market value or net income listing standards.
  • Uncertain financing and compliance plan: Staff noted the absence of a definitive additional financing agreement viewed as necessary to regain and sustain compliance, leaving the company’s remediation plan uncertain.

Filing Explained

The denied compliance plan depended on proposed removal of redemption rights from Series A preferred stock and additional PIPE financing; Nasdaq found no definitive financing arrangement, leaving the company’s ability to cure the listing deficiency unresolved.

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Securities
The company received a delisting notice or transferred its listing to a different exchange.
Reported stockholders’ equity $2,091,324 Stockholders’ equity level cited in relation to Nasdaq Listing Rule 5550(b)
Nasdaq equity requirement $2.5 million Minimum stockholders’ equity required under Nasdaq Listing Rule 5550(b)
Alternative market value standard $35 million Required market value of listed securities alternative for continued Nasdaq listing
Alternative net income standard $500,000 Net income from continuing operations required in one or two of three fiscal years
Hearing request deadline 4:00 p.m. ET on July 22, 2026 Deadline to request Nasdaq Hearings Panel review to avoid automatic suspension
Potential trading suspension date July 24, 2026 Date trading in common stock would be suspended absent a timely hearing request
Nasdaq Listing Rule 5550(b) regulatory
"did not comply with Nasdaq Listing Rule 5550(b)."
A Nasdaq listing rule that requires companies on the Nasdaq Capital Market to keep their share price at or above a minimum level (commonly $1.00 per share) to avoid delisting. It matters to investors because dropping below that threshold can start a formal review that may remove a stock from the exchange, which can reduce trading liquidity, make shares harder to sell, and hurt a company’s ability to raise capital — similar to a store losing its grade and being forced to close or move to a less prominent location.
Staff Delisting Determination regulatory
"received a Staff Delisting Determination letter (the “Determination”)"
A staff delisting determination is a formal finding by exchange or regulatory staff that a listed security no longer meets the rules required to stay listed, similar to an official notice that a rental property no longer qualifies for occupancy. It matters to investors because it often precedes removal from the exchange, which can sharply reduce a stock’s visibility, trading liquidity and value, and may trigger urgent choices like selling, appealing the decision or seeking alternative markets.
Series A Convertible Redeemable Preferred Stock financial
"Certificate of Designation of its Series A Convertible Redeemable Preferred Stock"
Preferred shares issued in an early funding round that act like a hybrid between stock and a loan: they sit ahead of common shares for payouts if a company is sold or shuts down, can be converted into ordinary shares under set conditions, and may be redeemable meaning the company can buy them back. Investors care because these rights change how much money and control they ultimately receive, and they affect both downside protection and potential upside.
mezzanine equity financial
"remove its redemption rights and reclassify it from mezzanine equity to stockholders’ equity"
Mezzanine equity is a layer of financing that sits between bank loans and full ownership, combining elements of borrowed money and equity. It often gives lenders higher potential returns in exchange for taking more risk, sometimes with the option to convert into ownership or receive extra payments; think of it as a middle seat that pays more because it’s less secure than front-row debt. Investors watch it because it affects a company’s debt risk, potential dilution of ownership, and expected returns.
PIPE investor financial
"obtaining additional financing from the PIPE investor holding the Series A"
A pipe investor is a buyer who provides money to a publicly traded company through a private placement of shares or convertible securities, often called a PIPE (Private Investment in Public Equity). They act like a private lender stepping in to quickly fund a public company, and their participation can signal confidence or cause dilution for existing shareholders, so investors watch PIPE deals to assess short-term cash needs, ownership changes, and potential share-price impact.
Form 25-NSE regulatory
"Nasdaq will file a Form 25-NSE with the Securities and Exchange Commission."
Form 25‑NSE is an official filing used to notify the stock exchange that a company’s securities are being removed from trading on that exchange, similar to handing in a key when a shop closes. Investors care because removal ends public trading on that venue, often cutting liquidity and making it harder to buy or sell shares, which can affect a stock’s price and how quickly investors can access cash or exit positions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What Nasdaq compliance issue did Caring Brands (CABR) disclose?

Caring Brands disclosed that Nasdaq’s Listing Qualifications Staff issued a Staff Delisting Determination after the company failed to meet Nasdaq Listing Rule 5550(b) for continued listing. It reported insufficient stockholders’ equity and did not meet alternative market value or net income standards.

How much stockholders’ equity did Caring Brands (CABR) report versus Nasdaq’s requirement?

Caring Brands reported stockholders’ equity of $2,091,324, below Nasdaq’s minimum requirement of $2.5 million under Listing Rule 5550(b). This shortfall, combined with not meeting alternative market value or net income standards, triggered the continued listing deficiency and contributed to the Staff Delisting Determination.

What alternative Nasdaq listing standards are mentioned for Caring Brands (CABR)?

The company did not satisfy alternative Nasdaq standards requiring a market value of listed securities of at least $35 million or net income of $500,000 from continuing operations in the most recently completed fiscal year, or in two of the three most recently completed fiscal years, leading to continued noncompliance.

What happens to Caring Brands (CABR) stock if no Nasdaq hearing is requested?

If no hearing is requested by 4:00 p.m. ET on July 22, 2026, trading in Caring Brands’ common stock will be suspended at the opening on July 24, 2026, and Nasdaq will file a Form 25-NSE to remove the securities from listing and registration.

What steps does Caring Brands (CABR) plan to take regarding the Nasdaq Determination?

Caring Brands intends to submit a hearing request to a Nasdaq Hearings Panel and pay the applicable fee by July 21, 2026. A timely request would stay any trading suspension and Form 25-NSE filing while the Panel considers the company’s appeal and compliance plan.

How did Caring Brands (CABR) plan to regain Nasdaq compliance?

The company’s plan contemplated amending the Series A Convertible Redeemable Preferred Stock Certificate of Designation to move it from mezzanine equity to stockholders’ equity and obtaining additional financing from the PIPE investor, but Staff noted no definitive financing agreement had been executed.
false 0002020737 0002020737 2026-07-15 2026-07-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): July 15, 2026

 

Caring Brands, Inc.

(Exact name of registrant as specified in its charter)

 

Nevada   001-42941   99-4103908

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

130 S Indian River Drive,

Suite 202 pbm# 1232,

Fort Pierce, FL 34950

(Address of principal executive offices, including zip code)

 

Registrant’s telephone number, including area code: (561) 896-7616

 

Not Applicable
(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
         
Common Stock, par value $0.001 per share   CABR   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 3.01Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

 

As previously disclosed, on April 7, 2026, Caring Brands, Inc. (the “Company”) received notice from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) that the Company did not comply with Nasdaq Listing Rule 5550(b). The Company reported stockholders’ equity of $2,091,324, below the required $2.5 million. The Company also did not satisfy either of the alternative continued listing standards, namely, market value of listed securities of at least $35 million or net income of $500,000 from continuing operations in the most recently completed fiscal year, or in two of the three most recently completed fiscal year.

 

On July 15, 2026, the Company received a Staff Delisting Determination letter (the “Determination”) denying the Company’s request for continued listing on The Nasdaq Capital Market. The Company’s compliance plan contemplated (i) amending the Certificate of Designation of its Series A Convertible Redeemable Preferred Stock to remove its redemption rights and reclassify it from mezzanine equity to stockholders’ equity and (ii) obtaining additional financing from the PIPE investor holding the Series A Convertible Redeemable Preferred Stock. Staff determined that the Company had not entered into a definitive agreement or arrangement for the additional financing, which Staff considered necessary for the Company to regain and maintain compliance. Accordingly, Staff concluded that the Company had not provided a definitive plan demonstrating its ability to achieve near-term compliance and sustain such compliance over an extended period.

 

The Determination stated that, unless the Company requests a hearing before a Nasdaq Hearings Panel (the “Panel”) by 4:00 p.m. Eastern Time on July 22, 2026, trading in the Company’s common stock will be suspended at the opening of business on July 24, 2026, and Nasdaq will file a Form 25-NSE with the Securities and Exchange Commission. The Company intends to submit a hearing request and pay the applicable fee by July 21, 2026. A timely hearing request will stay the suspension and the filing of the Form 25-NSE pending the Panel’s decision, and the Company’s common stock will continue to trade on Nasdaq during the appeal process. There can be no assurance that the Panel will grant the Company’s request for continued listing or that the Company will regain or maintain compliance with Nasdaq’s continued listing requirements.

 

Forward-Looking Statements

 

This Current Report on Form 8-K contains forward-looking statements, including statements regarding the Company’s intention to request a hearing before the Nasdaq Hearings Panel, its plans to pursue measures to regain compliance with Nasdaq’s continued listing requirements, and its ability to maintain the listing of its common stock on Nasdaq. Actual results may differ materially from those expressed or implied by these statements due to various risks and uncertainties, including the outcome of the hearing, the Company’s ability to obtain additional financing, amend the terms of its Series A Convertible Redeemable Preferred Stock, implement an acceptable compliance plan, and regain and maintain compliance with Nasdaq’s continued listing requirements. Additional risks are described in the Company’s Annual Report on Form 10-K and its other filings with the Securities and Exchange Commission.

 

These forward-looking statements reflect the Company’s current expectations and projections based on information available as of the date of this Current Report on Form 8-K and are subject to a number of risks and uncertainties, including, but not limited to, general economic, financial, and business conditions; changes in consumer demand and industry trends; the Company’s ability to successfully implement its strategic initiatives; competition in the relevant market; supply chain disruptions; regulatory compliance and legal proceedings; and other risks detailed from time to time in the Company’s filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K. The Company cautions investors that forward-looking statements are not guarantees of future performance and actual results may differ materially from those projected. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: July 17, 2026 Caring Brands, Inc.
     
  By: /s/ Glynn Wilson
  Name: Dr. Glynn Wilson
  Title: Chief Executive Officer

 

 

 

Filing Exhibits & Attachments

3 documents